Back to top

Can-Fite BioPharma secures Australian Patent Office allowance for namodenoson

Can-Fite BioPharma (CANF) announced that the Australian Patent Office has allowed Patent Application No. 2021290439 entitled “Treatment of Advanced...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Can-Fite Biopharma Ltd (CANF)